Defining infection risk of bispecific antibodies for myeloma

被引：0
|
作者：
Hammond, Sarah P. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Div Infect Dis & Hematol Oncol, Boston, MA 02114 USA
[2] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD ADVANCES | 2024年 / 8卷 / 18期
关键词：
D O I：
10.1182/bloodadvances.2024013813
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4977 / 4978
页数：2
相关论文
共 50 条
  • [31] The evolving status of immunotherapies in multiple myeloma: the future role of bispecific antibodies
    Swan, Dawn
    Routledge, David
    Harrison, Simon
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (03) : 488 - 506
  • [32] Response Outcomes, Neutropenia, and Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma - Pooled Analysis
    Aggarwal, Ankita
    Tabagari, David
    Vosuri, Venkata
    Chelapareddy, Lakshmi Ramya
    Naha, Kushal
    Hildebrandt, Gerhard
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S481 - S481
  • [33] Bispecific Antibodies in Multiple Myeloma: Opportunities to Enhance Efficacy and Improve Safety
    Swan, Dawn
    Murphy, Philip
    Glavey, Siobhan
    Quinn, John
    CANCERS, 2023, 15 (06)
  • [34] Bispecific Antibodies for Multiple Myeloma: Recent Advancements and Strategies for Increasing Their Efficacy
    Wang, Moran
    Wang, Chaofan
    Deng, Jun
    Wang, Huafang
    Sun, Chunyan
    Luo, Shanshan
    Hu, Yu
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (06):
  • [35] Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
    Landgren, Ola
    Nadeem, Omar
    ADVANCES IN THERAPY, 2023, 40 (08) : 3291 - 3303
  • [36] Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis
    Reynolds, Gemma
    Cliff, Edward R. Scheffer
    Mohyuddin, Ghulam Rehman
    Popat, Rakesh
    Midha, Shonali
    Hing, Melissa Ng Liet
    Harrison, Simon J.
    Kesselheim, Aaron S.
    Teh, Benjamin W.
    BLOOD ADVANCES, 2023, 7 (19) : 5898 - 5903
  • [37] Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives
    Parrondo, Ricardo D.
    Ailawadhi, Sikander
    Cerchione, Claudio
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [38] Early infections in myeloma patients treated with anti-BCMA bispecific antibodies
    Radocha, Jakub
    Pour, Ludek
    Jelinek, Tomas
    Minarik, Jiri
    Jungova, Alexandra
    Novakova, Denisa
    Stork, Martin
    Muronova, Ludmila
    Pika, Tomas
    Hajek, Roman
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S57 - S58
  • [39] Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
    Ola Landgren
    Omar Nadeem
    Advances in Therapy, 2023, 40 : 3291 - 3303
  • [40] Current status of bispecific antibodies and CAR-T therapies in multiple myeloma
    Szlasa, Wojciech
    Dybko, Jaroslaw
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 134
12345